Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin.

× No keyword cloud information.

34 in total

1. A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator.

Authors: G L Reed; A K Houng; L Liu; B Parhami-Seren; L H Matsueda; S Wang; L Hedstrom
Journal: Proc Natl Acad Sci U S A Date: 1999-08-03 Impact factor: 11.205

Review 2. Streptokinase--the drug of choice for thrombolytic therapy.

Authors: Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal: J Thromb Thrombolysis Date: 2007-02 Impact factor: 2.300

3. Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis.

Authors: N Baziuk; T Fang; G A Peyman; C M Gremillion
Journal: Int Ophthalmol Date: 1991-03 Impact factor: 2.031

4. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.

Authors: L C Petersen; J Brender; E Suenson
Journal: Biochem J Date: 1985-01-01 Impact factor: 3.857

Review 5. Studies on rat mammary adenocarcinomas: a model for metastasis.

Authors: I A Ramshaw; P Badenoch-Jones
Journal: Cancer Metastasis Rev Date: 1985 Impact factor: 9.264

Review 6. Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction.

Authors: S Noble; D McTavish
Journal: Drugs Date: 1996-10 Impact factor: 9.546

7. Expression of a novel chimeric truncated t-PA in CHO cells based on in silico experiments.

Authors: Fatemeh Davami; Soroush Sardari; Keivan Majidzadeh-A; Mehdi Hemayatkar; Farzaneh Barkhrdari; Maryam Omidi; Mehrnaz Azami; Ahmad Adeli; Noushin Davoudi; Fereidoun Mahboudi
Journal: J Biomed Biotechnol Date: 2010-09-22

8. Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.

Authors: R I Levin; P C Harpel; D Weil; T S Chang; D B Rifkin
Journal: J Clin Invest Date: 1984-08 Impact factor: 14.808

Review 9. Adverse reactions to thrombolytic agents. Implications for coronary reperfusion following myocardial infarction.

Authors: J Nazari; R Davison; K Kaplan; D Fintel
Journal: Med Toxicol Adverse Drug Exp Date: 1987 Jul-Aug

Review 10. Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.

Authors: A J Wagstaff; J C Gillis; K L Goa
Journal: Drugs Date: 1995-08 Impact factor: 9.546